BEROCCA PN | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

BEROCCA PN
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

BEROCCA PN

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 10 USDMF, 9 CEP/COS, 14 JDMF, 3 EU WC, 10 KDMF, 6 NDC API, 39 Listed Suppliers, $ API Reference Price

69 API Suppliers
10 USDMF
9 CEP/COS
14 JDMF
3 EU WC
10 KDMF
6 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

95 Drugs in Development

95 Drugs in Development

FINISHED DOSAGE FORMULATIONS

348 FDF Dossiers, 21 FDA Orange Book, 53 Europe, 10 Canada, 65 South Africa, 199 Listed Dossiers

348 FDF Dossiers
21 FDA Orange Book
53 Europe
10 Canada
65 South Africa
199 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML), SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML)
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 6 Evonik, 13 Rochem International Inc, 23 SPI Pharma, 30 DKSH, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 2 Kewpie Corporation, 13 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 20 Kirsch Pharma, 4 ACG Worldwide, 16 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 36 BASF, 2 Bioplus Life Sciences, 4 CD Formulation, 2 Clariant, 13 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 22 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 12 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 39 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

106 Fillers, Diluents & Binders, 62 Thickeners and Stabilizers, 61 Coating Systems & Additives, 56 Parenteral, 50 Taste Masking, 45 Solubilizers, 43 Direct Compression, 37 Disintegrants & Superdisintegrants, 35 Topical, 35 Granulation, 34 Controlled & Modified Release, 32 Film Formers & Plasticizers, 25 Chewable & Orodispersible Aids, 24 Lubricants & Glidants, 18 Rheology Modifiers, 17 Emulsifying Agents, 15 Co-Processed Excipients, 10 API Stability Enhancers, 9 Empty Capsules, 9 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

106 Fillers, Diluents & Binders
62 Thickeners and Stabilizers
61 Coating Systems & Additives
56 Parenteral
50 Taste Masking
45 Solubilizers
43 Direct Compression
37 Disintegrants & Superdisintegrants
35 Topical
35 Granulation
34 Controlled & Modified Release
32 Film Formers & Plasticizers
25 Chewable & Orodispersible Aids
24 Lubricants & Glidants
18 Rheology Modifiers
17 Emulsifying Agents
15 Co-Processed Excipients
10 API Stability Enhancers
9 Empty Capsules
9 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 27 News #PharmaBuzz

1 Data Compilation #PharmaFlow
27 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 28 Regulatory FDF Prices

7 US Medicaid Prescriptions
28 Regulatory FDF Prices

MARKET PLACE

184 APIs, 34 FDF Dossiers, 15 EXCIPIENTS

184 APIs
34 FDF Dossiers
15 EXCIPIENTS

PATENTS & EXCLUSIVITIES

11 US Patents, 3 Health Canada Patents

11 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 3 JP, 6 Others

5 EDQM
3 JP
6 Others

ANALYTICAL

11 Analytical Methods

11 Analytical Methods

$ API Ref.Price (USD/KG) : 13 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Bausch Health, Canada Inc.

filter Patent Reset all filters

3 All

01 12829825

02 12884472

03 12942089

filter Product Reset all filters

3 All

01 3POLYETHYLENE GLYCOL 3350 | SODIUM ASCORBATE | SODIUM SULPHATE ANHYDROUS | ASCORBIC ACID | SODIUM CHLORIDE | POTASSIUM CHLORIDE

filter Dosage Reset all filters

3 All

01 3KIT

filter Exp Date Reset all filters

3 All

01 11932-03-09

02 11933-09-10

03 11935-03-09

Product Main Page

01

Bausch Health, Canada Inc.

Polyethylene Glycol 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, Potassium Chloride

CPhI Korea

Not Confirmed

Bausch Health, Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 1932-03-09

Date Granted : 2019-10-22

Polyethylene Glycol 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, Potassium Chloride

Brand Name : PLENVU

Patent Number : 2829825

Filing Date : 2012-03-09

Strength per Unit : 140 grams of PEG 3350, 48.11 grams of sodium ascor

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 1932-03-09

Date Granted : 2019-10-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bausch Health, Canada Inc.

Polyethylene Glycol 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, Potassium Chloride

CPhI Korea

Not Confirmed

Bausch Health, Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 1933-09-10

Date Granted : 2021-06-22

Polyethylene Glycol 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, Potassium Chloride

Brand Name : PLENVU

Patent Number : 2884472

Filing Date : 2013-09-10

Strength per Unit : 140 grams of PEG 3350, 48.11 grams of sodium ascor

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 1933-09-10

Date Granted : 2021-06-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bausch Health, Canada Inc.

Polyethylene Glycol 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, Potassium Chloride

CPhI Korea

Not Confirmed

Bausch Health, Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 1935-03-09

Date Granted : 2021-10-19

Polyethylene Glycol 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, Potassium Chloride

Brand Name : PLENVU

Patent Number : 2942089

Filing Date : 2015-03-09

Strength per Unit : 140 grams of PEG 3350, 48.11 grams of sodium ascor

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 1935-03-09

Date Granted : 2021-10-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!